The groundbreaking therapy of tirzepatide peptide represents a significant advance in the care of type 2 diabetes. Unlike existing therapies, tirzepatide affects two pathways – GLP-1 and GIP – leading to improved https://tirzepatidepeptide521678.ja-blog.com/42399173/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment